| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.28 | 0.08 |